Why Early-Phase Clinical Trials Matter More Than Most People Realize
Understanding the True Purpose of Early-Phase Trials Early-phase clinical trials are often misunderstood as preliminary steps with limited scientific value. In reality, they are one of the most critical stages in the entire drug development process. As a translational researcher in hematologic malignancies, I view these trials as the first structured opportunity to evaluate whether […]
What It Really Takes to Build a New Cancer Therapy from Scratch
Understanding the Starting Point: Unmet Medical Need Building a new cancer therapy begins not with a molecule, but with a clinical problem that has not yet been solved. In hematologic malignancies such as multiple myeloma and acute leukemia, the starting point is often disease relapse, resistance to existing treatments, or a lack of durable response […]